Prevent Blindness offers resources for Cataract Month, empowering patients and caregivers with knowledge on cataracts and ...

A recent US Count of International Trade decision was made on May 28 to permanently prohibit all tariffs imposed by President ...

Telomir-1 shows promising results in restoring vision and retinal structure in age-related macular degeneration, marking a ...

SpyGlass Pharma secures $75 million in Series D funding to enhance its innovative drug delivery platform for long-term ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

The trial will evaluate AXPAXLI in at least 555 patients in a multi-center, double-masked, randomized (2:2:1), 3-arm study.

The phase 3 trial observed the treatment of chronic night driving impairment in keratorefractive patients with reduced ...

The drug has been reported previously to cause neuropathy and hypersensitivity reactions in breast cancer patients.

At ARVO 2025, in Salt Lake City, Utah, Emma Lessieru, MD, PhD, talked about her poster on retina extracellular vesicles, and ...

Deep Parikh, MD, sat down with Emily Kaiser Maharjan from Optometry Times to talk about his presentation at Collaborative Care Symposium on advanced treatments in neovascular retinal disease.

At ARVO 2025, in Salt Lake City, Utah, Carly Lam, PhD, MSc, and Tsz Wing Leung, PhD talked about the evaluation of the visual ...

The Retina World Congress showcases global innovations in surgical and medical retina, highlighting emerging treatments and ...